Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02280733 · ClinicalTrials.gov registry record
A Real-World Registry of Chronic Wounds and Ulcers
A clinical trial of Peripheral Arterial Disease and Lymphedema, sponsored by U.S. Wound Registry.
- Recruiting
- Registry status
- 300,000
- Enrollment target
- 1
- Study location
NCT02280733 is a study of Peripheral Arterial Disease and Lymphedema that is actively recruiting participants, run by U.S. Wound Registry. The registered enrollment target is 300,000 participants, above the 409-participant average among 79 other Peripheral Arterial Disease trials with a reported enrollment target (73250% higher). The trial reports 1 study location across 1 state.
The verdict
NCT02280733, a study of Peripheral Arterial Disease and Lymphedema, is actively recruiting participants, sponsored by U.S. Wound Registry.
- RECRUITING
- Registry status
- 300,000 participants
- Enrollment target
- 1
- Study location
Study Summary
WOUNDJOURNEY is a longitudinal, real-world, observational registry designed to capture the full clinical course and patient journey associated with chronic wounds and ulcers. Data are collected during routine care from over 1,400 clinicians across the USA and Puerto Rico using a highly structured certified electronic health record (EHR) or electronic data capture (EDC) system. Data are transmitted daily to the U.S. Wound Registry (USWR), a CMS-recognized Qualified Clinical Data Registry (QCDR). The registry captures real-time, research-ready data on patient demographics, comorbidities, wound characteristics, standard-of-care treatments, complications, and advanced therapeutics. It supports robust, fit-for-purpose real-world evidence generation by enabling risk-adjusted outcome analysis, comparative effectiveness research, and quality improvement across diverse sites of care.
Conditions Studied
Interventions
- OTHER Usual care
Study Locations (1)
Texas
- US Wound Registry - The Woodlands
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300,000 participants |
| Start Date | 2005-01-01 |
| Est. Completion | 2030-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02280733
The ClinicalTrials.gov registry entry for NCT02280733 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 300,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 409-participant average among 79 other Peripheral Arterial Disease trials with a reported enrollment target (73250% higher). The listed sponsor is U.S. Wound Registry, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 10 conditions, with Peripheral Arterial Disease appearing as the primary indexed condition, and to 1 intervention - of which Usual care is the first listed.
NCT02280733 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT02280733 about?
NCT02280733 is a clinical study titled "A Real-World Registry of Chronic Wounds and Ulcers". WOUNDJOURNEY is a longitudinal, real-world, observational registry designed to capture the full clinical course and patient journey associated with chronic wounds and ulcers. Data are collected during routine care from over 1,400 clinicians across the USA and Puerto Rico using a highly structured ce...
What is the current status of trial NCT02280733?
This trial is currently recruiting. The enrollment target is 300,000 participants. The study started on 2005-01-01. Estimated completion is 2030-01.
What conditions does trial NCT02280733 study?
This clinical trial studies the following conditions: Peripheral Arterial Disease, Lymphedema, Diabetic Foot, Vasculitis, Pressure Ulcer.
What interventions are being tested in trial NCT02280733?
The interventions under investigation include: Usual care (OTHER).
Who is sponsoring clinical trial NCT02280733?
This trial is sponsored by U.S. Wound Registry, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02280733 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Peripheral Arterial Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
SELUTION4BTK Trial
RECRUITING · NA
-
MitoQ Treatment of Claudication: Myofiber and Micro-vessel Pathology
RECRUITING · NA
-
Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk
RECRUITING · Phase 3
-
Ramipril Treatment of Claudication: Oxidative Damage and Muscle Fibrosis
RECRUITING · Phase 4
-
Ultrasound Perfusion Estimation for Assessment of Peripheral Arterial Disease
RECRUITING · NA
-
Prehabilitation and Rehabilitation in PAD
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.